BNET Industries
Last Fiscal Year Sales:$299.9M
- Private
- US
Dow Jones Description
Designs, develops and manufactures excimer refractive surgical systems designed to recontour the front surface of the cornea of the human eye. (Nasdaq: VISX).
Chief Executive Officer
Elizabeth H. DavilaNumber of Employees 250
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
News & Analysis
Filter by
visx - All News and Analysis
VISX Stockholders Approve Merger Agreement with Advanced Medical Optics
SANTA CLARA, Calif. -- VISX, Incorporated (NYSE:EYE) announced today that at a special meeting of its stockholders held this morning, the terms of the merger agreement and merger between VISX and Advanced Medical Optics, Inc. was approved by the majority of VISX stockholders. As previously announced, VISX anticipates closing...
VISX Announces Release Date for First Quarter 2005 Financial Results
SANTA CLARA, Calif. -- VISX, INCORPORATED (NYSE:EYE) announced today that it will release its first quarter 2005 financial results before the market opens on Tuesday, April 26, 2005. A copy of the release may be obtained through the Company's web site at www.visx.com or by contacting the VISX Investor Relations...
VISX Fourth Quarter Results Conference Call
SANTA CLARA, Calif. -- VISX, INCORPORATED (NYSE:EYE) announced today that it will webcast its fourth quarter 2004 financial results conference call at 4:30 p.m. Eastern Time on Thursday, February 10, 2005. During the call, VISX management will discuss its financial results and business outlook. The call will contain forward-looking statements...
AMO to Acquire VISX for $1.27 Billion
COMPANY BOASTS WIDE PRODUCT LINE, GLOBAL REACH* Advanced Medical Optics AMO, the ophthalmic surgical devices and eyecare products company, announced it will purchase VISX, a manufacturer of laser vision correction technologies, for $1.27 billion. The transaction, which will create a $1 billion global enterprise, is expected to close in the...
AMO to acquire VISX.(NEWS REVIEW)(Brief Article)
Advanced Medical Optics Inc. AMO will acquire VISX Incorporated. The merger will create a $1 billion global ophthalmic company, which will retain the Advanced Medical Optics name. Upon completion of the transaction, AMO's stockholders will own approximately 58.5% of the combined company, and VISX's stockholders will...
VISX Operating Profit Up 89 Percent
SANTA CLARA, Calif. -- VISX, Incorporated (NYSE:EYE) today announced financial results for the third quarter and nine months ended September 30, 2004. Third quarter revenues were $38.7 million compared with $39.3 million for the comparable period of 2003. Operating income increased 89 percent, due to a favorable product mix...
VISX to Webcast Third Quarter Results Conference Call
SANTA CLARA, Calif. -- VISX, Incorporated (NYSE:EYE) announced today that it will webcast its third quarter 2004 financial results conference call at 4:30 p.m. Eastern Time on Thursday, October 21, 2004. During the call, VISX management will discuss its financial results and business outlook. The call will contain forward-looking statements...
VISX to Present at Upcoming Health Care Conferences
SANTA CLARA, Calif. -- VISX, Incorporated (NYSE:EYE) today announced that its chairman and chief executive officer, Liz Davila, will present at the ThinkEquity Partners Growth Conference 2004 to be held on September 22, 2004, at 1:30 p.m. ET and the 2004 UBS Global Life Sciences Conference on September 28, 2004,...
VISX Second Quarter Earnings Grow 133 Percent on 34 Percent Higher Revenue; CustomVue Adoption and Increased Procedure Volume Drive EPS Growth
SANTA CLARA, Calif. -- VISX, Incorporated (NYSE:EYE) today announced financial results for the second quarter and six months ended June 30, 2004. Second quarter revenues increased 34 percent to $43.0 million from $32.0 million for the comparable period of 2003. Net income increased 133 percent to $9.5 million, or...
VISX to Webcast Second Quarter Results Conference Call
SANTA CLARA, Calif. -- VISX, INCORPORATED (NYSE:EYE) announced today that it will webcast its second quarter 2004 financial results conference call at 4:30 p.m. ET on Wednesday, July 21, 2004. During the call, VISX management will discuss its financial results and business outlook. The call will contain forward-looking statements and...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Elizabeth H. Davila | Chief Executive Officer |
| Mark B. Logan | Chief Executive Officer |
| Dan Beers | Principal Investigator |
| Donald Fagen | Sales Executive |
| Marguerite B McDonald | Senior Consultant |
| Mark E Whitten | Clinical Instructor |
| Glendon E French | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Gary S. Petersmeyer | Board of Directors |
| Laureen DeBuono | Member of the Board of Directors |
| Neal A Sher | Advisory Board |
| Organization | Position | Status |
|---|---|---|
| Advanced Medical Optics, Inc. | Board of Directors | Current |
| Cyberknife | Board of Directors | Current |
| Accuray Incorporated | Board of Directors | Current |
| Nugen Technologies, Inc. | Board of Directors | Current |
| Accuray Incorporated | Committee Member | Current |
| VISX | Chief Executive Officer | Former |
| VISX | president | Former |
| VISX | Chief Operating Officer | Former |
| VISX | executive vice president | Former |
| Syntex Corporation | Former | |
| VISX | Chairman of the Board | Former |
| Cholestech Corporation | Board of Directors | Former |
| Stanford University | MBA | Former |
| University of Notre Dame | masters degree in Chemistry | Former |
| Stanford University | B.S. In Chemistry | Former |
| St. Mary's College | B.S. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| VISX | Chief Executive Officer | Current |
| Public Policy Virginia, Inc. | Is A Director | Current |
| Vivus, Inc. | Chairman | Current |
| Orbimed Advisors, LLC | Director | Current |
| Vivus, Inc. | Director | Current |
| Tall Oaks Capital | Board of Directors | Current |
| Public Policy Virginia, Inc. | Director | Current |
| Green Choice Virginia | Board of Directors | Current |
| Southern Environmental Law Center | Board of Directors | Current |
| VISX | President | Former |
| Bausch & Lomb Incorporated | Senior Vice President, Healthcare and Consumer Group | Former |
| VISX | Chairman of the Board | Former |
| Amgen Fremont | Director | Former |
| Hiram College | B.A. | Former |
| Harvard Business School | P.M.D. | Former |
Daniel J. Beers MD is an ophthalmic surgeon specializing in laser vision correction and cataract surgery. He has successfully performed over 10,000 LASIK, cataract and lens implant procedures. He is the Chief of Ophthalmology at El Camino Hospital and he teaches the latest techniques to the ophthalmologists in training at Stanford University. As an expert in his field, Dr. Beers has given presentations about advances in laser vision correction to the American Society of Cataract and Refractive Surgeons. He is currently a principal investigator with VISX and has been named "one of the top ophthalmologists in Silicon Valley" by San Jose magazine. Dr. Beers uses the newest generation of the VISX Wavefront and Intralase systems to provide patients with the safest and most accurate form of laser vision correction available. He has treated many physicians in the Bay Area and has had laser vision correction himself. Dr. Beers prides himself on careful personalized planning of each LASIK surgery to maximize patient safety and quality of vision. As an expert in cataract surgery, Dr. Beers utilizes a small incision to allow for rapid recovery for his patients. He implants a variety of the most advanced intraocular lenses including Crystalens, Restore, and Rezoom to allow patients to see well in the distance as well as up close. He is also one of the few surgeons in the area to complete advanced training to implant the Visian implantable collomer lens for patients that are not candidates for either laser vision correction or cataract surgery. Dr. Beers was raised in San Jose and graduated as the valedictorian at Cupertino High School. He attended UC San Diego where he graduated Cum Laude and Phi Beta Kappa while winning the NCAA Tennis Doubles Championship and becoming an NCAA All-American. Dr. Beers completed medical school at the prestigious UC San Francisco where he graduated in the top tier of his class. His advanced ophthalmology training was completed at Oregon Health Sciences where he participated in early FDA studies concerning the excimer laser and laser vision correction. Dr. Beers is an active member of the Academy of Ophthalmology and the American Society of Cataract and Refractive Surgeons. He speaks fluent Spanish and has traveled to Peru and Mexico to provide charity medical care. He enjoys outdoor activities such as golf and biking and resides in Los Altos with his wife Katie and their two daughters Kimberly and Allison.
| Organization | Position | Status |
|---|---|---|
| El Camino Hospital | Chief | Current |
| VISX | Principal Investigator | Current |
| Peninsula Laser Eye Medical Group | Mountain View and San Jose Area Lasik Eye Surgeon | Current |
| Academy of Ophthalmology, Inc. | Board of Directors | Current |
| American Academy of Ophthalmology, Inc. | Board of Directors | Current |
| American Academy of Ophthalmology, Inc. | Member | Current |
| Organization | Position | Status |
|---|---|---|
| VISX | Sales Executive | Current |
| Organization | Position | Status |
|---|---|---|
| VISX | Senior Consultant | Current |
| Tulane University School of Medicine | Clinical Professor | Current |
| Ophthalmic Consultants of Long Island | Current | |
| Epi-Lasik News and Information | Current | |
| Biosyntrx, Inc. | Board of Directors | Current |
| Ocularis Pharma, Inc. | Board of Directors | Current |
| 3D Vision Systems LLC. | Board of Directors | Current |
| Chiron Technologies, Inc. | Principal Investigator | Former |
| Louisiana.Com | Clinical Prof | Former |
| Ophthalmology, Ltd. | Professor | Former |
| Organization | Position | Status |
|---|---|---|
| TLC Laser Eye Centers | Regional Medical Director | Current |
| VISX | Clinical Instructor | Current |
| Alcon Laboratories, Inc. | Instructor | Current |
| Whitten-Perraut Laser Eye Associates | Current | |
| Laser Vision Centers, Inc. | Current | |
| American Academy of Ophthalmology, Inc. | Council Member | Current |
| Washington Hospital Center | chief residency | Former |
| TLC, LLC | Former | |
| Washington Hospital Center | Chairman of the Board | Former |
| Medical College of Virginia | Doctorate | Former |
| University of Virginia | Undergraduate Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Positive Coaching Alliance | Chairman of the Board | Former |
| VISX | Board of Directors | Current |
| Eunoe, Inc | Board of Directors | Current |
| Omnicell Inc. | Board of Directors | Current |
| Percy's | Board of Directors | Current |
| Roxro Pharma, Inc | Board of Directors | Current |
| Harvard Graduate School of Education | Board of Directors | Current |
| Stanford University | Board of Directors | Current |
| Harvard University | Board of Directors | Current |
| Collagen Corporation | CEO | Former |
| Collagen Corporation | President | Former |
| Collagen Corporation | Chief Operating Officer | Former |
| Coopervision, Inc. | Senior Executive | Former |
| Syntex Corporation | Senior Executive | Former |
| Collagen Corporation | Director | Former |
| Harvard University | M.B.A. | Former |
| Harvard Graduate School of Education | M.A. In Teaching | Former |
| Stanford University | Bachelor of Arts Degree In Political Science | Former |
| Organization | Position | Status |
|---|---|---|
| Atairgin Technologies, Inc. | Director | Current |
| VISX | Director | Current |
| Dartmouth College | M.B.A. | Former |
| Dartmouth College | B.A. In Business | Former |
| Organization | Position | Status |
|---|---|---|
| Coapt Systems, Inc. | President and Chief Executive Officer | Current |
| VISX | Member of the Board of Directors | Current |
| Critical Path, Inc. | Cfo | Former |
| SOLTA MEDICAL, INC. | CFO | Former |
| Resound Corp | Cfo | Former |
| The Clorox Company | Corporate Counsel | Former |
| Nellcor Puritan Bennett Inc. | General Counsel | Former |
| Invivo, Inc | Board of Directors | Former |
| New York University School of Law | Jd | Former |
| Stanford University | Ma | Former |
| Duke University | Ba | Former |
A New York native, Dr. Sher received his BA. and MD. degrees with honors from Boston University at the age of 22. After a pediatric internship at the University of Minnesota Hospitals, he entered the U.S. Public Health Service as a commissioned officer in 1972 and served in the USPHS as a staff associate at the National Institute of Health. He spent the next three at the NIH in Bethesda, Maryland, performing tumor immunology and immunotherapy research and authoring a number of papers in that field. At the NIH, he became interested in ocular immunology and decided to train in ophthalmology. He then completed ophthalmology residency at the University of Minnesota followed by additional corneal and external disease training at Moorfield's Eye Hospital in London, UK. Returning to Minneapolis in 1979, he went into private practice. He is currently a partner in Eye Care Associates, a group of 8 ophthalmologists and optometrists with several offices in Minneapolis. Dr. Sher is an attending surgeon at the Phillips Eye Institute where he was a founding member in 1984 and has served as Chief of Ophthalmology. Active in teaching other doctors and students, Dr. Sher has been on the adjunct faculty of the University of Minnesota Medical School since 1979 and currently holds the rank of Clinical Professor of Ophthalmology. Since 1988, Dr. Sher has devoted considerable time to studying and working in the field of refractive surgery. He holds several patents on related medical devices. He has authored or co-authored more than 75 scientific papers or book chapters, is a frequent lecturer, and is a reviewer for a number of scientific journals. In 1994, Dr. Sher was the first American to be awarded prestigious Troutman Award by the International Society for Refractive Surgery for his paper on the control of pain using diclofenac after PRK. He is the editor of a textbook entitled Surgery for Hyperopia and Presbyopia, published in 1997 by Williams and Wilkins. It was the first book devoted to this topic. A new textbook edited by Dr. Sher, Surgery for Hyperopia,was published by Slack Inc. in November 03. He authored a monograph on postoperative care after laser corneal surgery (PRK) and edited an Atlas of Refractive Surgery for the American Academy of Ophthalmology (AAO) Dr. Sher has been the principal investigator or co-investigator for a number ophthalmologic clinical trials as well as a consultant for a number of ophthalmic-related companies including VISX Inc. He has served as a member of the Preferred Practice Patterns Panel of the American Academy of Ophthalmology for Refractive Errors and Refractive Surgery. Additionally, he has served on the editorial board of EyeWorld and Clinical Signs in Ophthalmology. He has helped develop evaluation tools for the quantification of ocular injury to toxic gases such as ammonia and chlorine.
| Organization | Position | Status |
|---|---|---|
| Eye Care Associates Inc. | Partner | Current |
| University of Minnesota Medical School | Faculty | Current |
| Dr. Sher | Refractive Surgery Specialist | Current |
| Medicolegal Ophthalmology | Ophthalmic Surgeon | Current |
| H Y P E R O P I A | Editor | Current |
| VISX | Advisory Board | Current |
| Ophthalmology, Ltd. | Chief | Former |
| University of Minnesota | Residency | Former |
| Boston University | M.D. Degrees With Honors | Former |
| Boston University | BA. | Former |
| Boston University | MD. Degrees | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes



